Some big drugs see big changes,
but most stable in Q2 drug prices
Stability was the watchword for CMS’ second-quarter 2013 average sales price (ASP) list recently released by CMS. Price rises and drops were mostly modest; only two drugs were removed from the list; and a few popular drugs that saw big movement in the first quarter have seen their prices normalized.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.